Condition Guide
Updated April 2026
8 min read

Red Light Therapy for Fibromyalgia: What a Meta-Analysis Found

20+ years of research ✓ FDA 510(k) Cleared 4.8/5 rating 30-days free trial

If you've been living with fibromyalgia, you know the exhaustion of searching for something that actually works. Years of pain, fatigue, and limited treatment options can wear you down. The good news: a systematic review and meta-analysis of red light therapy in fibromyalgia found it to be effective, safe, and well-tolerated. In this article, we break down what the research shows, how the mechanism works for fibromyalgia specifically, and how to use the MOVE+ as part of your fibromyalgia management plan.

Understanding Fibromyalgia and Why Treatment Is Hard

Fibromyalgia is a chronic pain condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbance, and often cognitive changes ("fibro fog"). Unlike conditions with clear structural damage, fibromyalgia involves central nervous system dysfunction—pain signaling is amplified, and the body struggles to regulate pain and energy.

This makes fibromyalgia notoriously difficult to treat. Medications help some people but not others. Physical therapy can be painful to start. Many patients cycle through treatments, each providing temporary relief at best. This is why finding an evidence-based, non-medication option like red light therapy can be transformative for many people.

What the Meta-Analysis Found

In 2019, researchers published a systematic review and meta-analysis in Lasers in Medical Science examining the effectiveness of low-level laser therapy (photobiomodulation) in fibromyalgia. The analysis found that LLLT is effective, safe, and well-tolerated in fibromyalgia, significantly reducing pain and fatigue.

More recently, a 2025 umbrella review of photobiomodulation across chronic pain conditions found that photobiomodulation shows the strongest evidence for fibromyalgia among chronic widespread pain conditions. This means fibromyalgia is one of the conditions where red light therapy has the most robust clinical support.

Key findings from the research:

  • Chris Bohler Significant decrease in visual analog scale (VAS) pain scores
  • Fatigue improvement: Reductions in fibromyalgia fatigue severity
  • Quality of life: Patients reported improved sleep, function, and overall well-being
  • Safety profile: Well-tolerated with minimal side effects
  • Duration: Benefits typically sustained for weeks to months after treatment

How Red Light Therapy Addresses Fibromyalgia Symptoms

Fibromyalgia involves both peripheral (local tissue) and central (nervous system) dysfunction. Red light therapy addresses multiple mechanisms:

Mitochondrial Enhancement: Photobiomodulation reduces inflammatory cytokines and promotes cellular energy. Fibromyalgia involves mitochondrial dysfunction and energy depletion in muscle cells. By enhancing ATP production, red light therapy helps cells have more energy for repair and function.

Inflammation Reduction: Fibromyalgia often involves elevated inflammatory markers. Red light therapy reduces IL-6, TNF-α, and other pro-inflammatory cytokines, helping to calm the overactive immune response that amplifies pain signaling.

Nerve Function Improvement: By reducing inflammation and enhancing cellular function, red light therapy may help restore normal pain signaling and reduce the central sensitization that makes fibromyalgia pain so severe.

Sleep Support: Many fibromyalgia patients report improved sleep quality with red light therapy, likely due to reduced pain, lower inflammation, and improved circadian rhythm regulation.

MOVE+ Protocol for Fibromyalgia

The MOVE+ is well-suited for fibromyalgia because it allows you to target pain areas from home. Here's how to use it effectively:

  • Target Areas: Apply to neck, shoulders, lower back, and any areas of widespread pain. For fibromyalgia, you may alternate target areas or use the device on multiple sites throughout the week.
  • Duration: Start with 10-15 minute sessions if you have heightened sensitivity. Increase gradually to 20-30 minutes as tolerated.
  • Frequency: Use 3-5 days per week. Clinical trials typically use 2-5 sessions weekly.
  • Timeline: Expect to assess benefit after 4-8 weeks of consistent use. Some patients report initial improvements in 2-3 weeks; others require longer.
  • Consistency: This is critical. Sporadic use won't produce lasting benefits. Build it into your daily routine.
  • Gradual Approach: Fibromyalgia often involves heightened sensitivity. Start conservatively and adjust based on how you feel.

Combine red light therapy with your existing fibromyalgia treatments—medications, physical therapy, sleep support, and stress management. Red light therapy is an adjunctive tool that works best alongside a comprehensive approach.

Finally — A Drug-Free Option With Real Clinical Evidence

The meta-analysis evidence for red light therapy in fibromyalgia is clear: it reduces pain, fatigue, and improves quality of life. If you've been searching for an effective, safe, evidence-based option you can use at home, MOVE+ is built for exactly this.

Explore MOVE+

Frequently Asked Questions

Yes. A 2019 systematic review and meta-analysis found red light therapy to be effective, safe, and well-tolerated in fibromyalgia, with significant reductions in pain, fatigue, and other symptoms. However, response varies by individual, and consistent use over 4-8 weeks is typically required to assess benefit.
The strongest evidence comes from a 2019 meta-analysis of low-level laser therapy in fibromyalgia, which found significant improvements in pain scores, fatigue, and quality of life. More recent umbrella reviews confirm that fibromyalgia is one of the chronic pain conditions with the strongest evidence for red light therapy effectiveness.
Most clinical trials use 15-30 minute sessions, 2-5 times per week for 4-12 weeks. Most patients report noticeable improvement within 4-8 weeks of consistent use. Individual response varies—some feel better sooner, others require longer. Consistency matters more than intensity.
Yes. The MOVE+ is FDA registered for home use and can be used to target areas of fibromyalgia pain. Follow the protocol guidelines for your condition and start with shorter sessions (10-15 minutes) if you have heightened sensitivity. Consult your rheumatologist before beginning.
Yes. Clinical studies show that red light therapy reduces both pain and fatigue in fibromyalgia. The mechanism involves improving mitochondrial function and reducing inflammation—both factors that contribute to pain and energy depletion in fibromyalgia.
Yes. Red light therapy works well as an adjunctive treatment alongside medications, physical therapy, and other interventions. Always inform your healthcare team of any new therapies you add so they can monitor your overall treatment plan and watch for any interactions.

Safety Considerations for Fibromyalgia

  • Heightened sensitivity: Start with shorter sessions (10-15 minutes) and gradually increase. Fibromyalgia often involves pain amplification, so conservative introduction is wise.
  • Avoid active skin conditions: Do not apply over areas with active rashes, eczema, or infections.
  • Consult your rheumatologist: Inform your doctor before beginning red light therapy so they can incorporate it into your treatment plan.
  • Consistency required: Results typically require 4-8 weeks of consistent use. Sporadic application won't produce lasting benefit.
  • Adjunctive use: Red light therapy is not a replacement for fibromyalgia medications, physical therapy, sleep support, or stress management. Use it as part of a comprehensive approach.

Related Articles

About the Author

CB
Chris Bohler Chief Technology Officer, Kineon

Chris Bohler is the Chief Technology Officer at Kineon, leading the engineering and product development of clinical-grade photobiomodulation devices. He holds a PhD in Physics from Missouri University of Science and Technology and brings over a decade of expertise in photonics and light-based technology, with previous roles at GE Lumination and Cooper Lighting. At Kineon, Chris applies his deep knowledge of optics and cellular light interaction to ensure every MOVE+ device delivers clinically validated wavelengths and irradiance for maximum therapeutic effect.

View LinkedIn Profile →

Key Referenced Researchers

The studies cited in this article were authored by recognised leaders in photobiomodulation research. Below is a brief overview of the principal investigators whose work forms the evidence base for this guide.

SY
Shu-Wei Yeh, MD & Colleagues Systematic Review Authors · Pain Physician, 2019

Yeh SW, Hong CH, Shih MC, Tam KW, Huang YH, and Kuan YC conducted the most comprehensive systematic review and meta-analysis evaluating LLLT for fibromyalgia, published in Pain Physician (2019). Their analysis of 9 RCTs (325 patients) concluded that low-level laser therapy is an effective, safe, and well-tolerated treatment for fibromyalgia.

EL
Ernesto Cesar Pinto Leal-Junior, PhD Full Professor · Nove de Julho University, São Paulo · Associate Professor, University of Bergen

Dr. Leal-Junior has authored over 140 peer-reviewed publications in photobiomodulation — more randomised controlled trials than any other researcher in the field. His research spans sports performance, muscular fatigue, tendinopathy, and post-exercise recovery. Supported by USD 3M+ in grants, he leads the Laboratory of Phototherapy and Innovative Technologies in Health (LaPIT) in Brazil.

View publications →